HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Solomon, A. Articles by Pflugfelder, S. C. Search for Related Content PubMed PubMed Citation Articles by Solomon, A. Articles by Pflugfelder, S. C.

Pro- and Anti-inflammatory Forms of Interleukin-1 in the Tear Fluid and Conjunctiva of Patients with Dry-Eye Disease

¹ From the Ocular Surface and Tear Center, Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, Florida; and the ² Zhongshan Ophthalmic Center, Sun Yat-sen University of Medical Sciences, Guangzhou, China.

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
PURPOSE. To compare the expression of the pro- and anti-inflammatory forms of interleukin (IL)-1 in the tear fluid and conjunctival epithelium of normal eyes and those with dry-eye disease.

METHODS. The concentrations of IL-1, IL-1ß (precursor and mature forms), and IL-1 receptor antagonist (IL-1Ra) were measured by ELISA in tear fluid samples obtained from normal individuals and patients with dry eye who had rosacea-associated meibomian gland disease (MGD) or Sjögren’s syndrome (SS) aqueous tear deficiency (ATD). These cytokines were also measured in normal tear fluid before and after nasal stimulation to induce reflex tearing. The relative expression of these cytokines was evaluated in conjunctival impression cytology specimens and conjunctival biopsy tissue obtained from normal subjects and SS ATD–affected patients using immunofluorescent staining. Matrix metalloproteinase (MMP)-9 concentration and activity in the tear fluid were evaluated with gelatin zymography and with an MMP-9 activity assay kit, respectively.

RESULTS. Compared with normal subjects, the concentration of IL-1 and mature IL-1ß in the tear fluid was increased, and the concentration of precursor IL-1ß was decreased in patients with MGD (P < 0.05, P = 0.02, and P < 0.01, respectively) and SS ATD (P < 0.001, P = 0.02, and P < 0.001, respectively). There was no significant change in the concentration of IL-1, precursor IL-1ß, and IL-1Ra in reflex tear fluid, indicating that the lacrimal glands may secrete these cytokines. The activity of MMP-9, a physiological activator of IL-1ß, was significantly elevated in the tear fluid of both dry-eye groups compared with normal subjects. A strong positive correlation was observed between the intensity of corneal fluorescein staining and the tear fluid IL-1 concentration (r² = 0.17, P < 0.02) and the mature-to-precursor IL-1ß ratio (r² = 0.46, P < 0.001). Positive immunofluorescent staining for IL-1, mature IL-1ß, and IL-1Ra was observed in a significantly greater percentage of conjunctival cytology specimens from eyes with SS ATD than in those from normal eyes (P < 0.01 for IL-1, P < 0.009 for mature IL-1ß, and P < 0.05 for IL-1Ra).

CONCLUSIONS. Dry-eye disease is accompanied by an increase in the proinflammatory forms of IL-1 (IL-1 and mature IL-1ß) and a decrease in the biologically inactive precursor IL-1ß in tear fluid. Increased protease activity on the ocular surface may be one mechanism by which precursor IL-1ß is cleaved to the mature, biologically active form. The conjunctival epithelium appears to be one source of the increased concentration of IL-1 in the tear fluid of patients with dry-eye disease. These results suggest that IL-1 may play a key role in the pathogenesis of keratoconjunctivitis sicca.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
There is increasing evidence that dry eye is accompanied by subclinical ocular surface inflammation. The evidence for this inflammation includes increased expression of immune activation markers, such as HLA-DR, intercellular adhesion molecule (ICAM)-1, and CD-40, by the conjunctival epithelium and infiltration of the conjunctiva by inflammatory cells.^{1 2 3 4 5 6 7} The importance of inflammation in the pathogenesis of dry eye is underscored by reports that the signs and symptoms of dry eye markedly improve with anti-inflammatory therapies such as glucocorticosteroids and cyclosporin.^{8 9}

Our group has previously evaluated the levels of the inflammatory cytokines that are capable of modulating the expression of these inflammatory markers and of stimulating leukocyte chemotaxis onto the ocular surface of dry eyes. Our studies showed that the levels of RNAs encoding a number of different inflammatory cytokines, including interleukin (IL)-1, -6, and -8 and TNF-, were elevated in the conjunctival epithelium of patients with Sjögren’s syndrome (SS) keratoconjunctivitis sicca (KCS) compared with normal subjects.¹⁰ The levels of IL-1 and -8 RNA are directly correlated with the intensity of corneal fluorescein staining and are inversely correlated with conjunctival goblet cell density. In a subsequent study, we found that the concentration of matrix metalloproteinase (MMP)-9, the principal MMP enzyme produced by the corneal epithelium and a key factor in the pathogenesis of sterile corneal ulceration, increases as tear clearance decreases.¹¹ The mechanism by which these inflammatory and matrix-degrading factors are upregulated in dry-eye disease has not been established.

The proinflammatory cytokine IL-1 is an important mediator of inflammation and immunity.¹² IL-1 has been implicated in the pathogenesis of human inflammatory diseases, such as septic shock, rheumatoid arthritis, and periodontitis,^{13 14 15} as well as the corneal and ocular surface diseases rosacea, bullous keratopathy, keratoconus, and sterile corneal ulceration.^{11 16 17} Both proinflammatory forms of IL-1 (IL-1 and -1ß) are multifunctional cytokines that in general produce similar biological effects, although these may vary among different cell types and organ systems.^{19 20} IL-1 is a potent inducer of other inflammatory cytokines such as IL-6 and -8, TNF-, and granulocyte-macrophage colony-stimulating factor (GM-CSF).^{21 22} It also stimulates production of MMP enzymes by epithelial and inflammatory cells.²³ Both IL-1 and -1ß are synthesized as precursor proteins with a molecular mass of approximately 33 kDa.¹⁹ The precursor and the mature 17-kDa forms of IL-1 are both biologically active.¹⁹ In contrast, the precursor form of IL-1ß possesses minimal biological activity and requires cleavage to the 17-kDa mature form to become active.¹⁹ This conversion occurs within cells by IL-1ß–converting enzyme (also known as ICE or caspase 1) and in the extracellular environment by a number of proteases, including leukocyte elastase, granzyme A, and MMP-2 and -9.^{12 24 25} Among a number of different MMPs evaluated, MMP-9 was found to be the most efficient activator of precursor IL-1ß.²⁵

IL-1Ra is a cytokine that inhibits the activities of the proinflammatory forms of IL-1 by competitively binding to the type 1 IL-1 receptor.²⁶ Administration of IL-1Ra has been found to be clinically beneficial in the treatment of arthritis and prevention of corneal transplant rejection in experimental models.^{14 27} Both proinflammatory forms (IL-1 and -1ß) and the anti-inflammatory form (IL-1Ra) of IL-1 have been detected in the human corneal epithelium.^{28 29 30 31} IL-1Ra has also been detected in human conjunctival epithelial cells.³² IL-1 and -1ß have also been detected in human tear fluid.^{11 33}

We hypothesized that increased concentration and/or activity of IL-1 could be an initiating factor for the observed ocular surface immunopathology of dry eye. This study was designed to test this hypothesis by comparing the concentrations of IL-1, inactive precursor and active mature IL-1ß and IL-1Ra in tear fluid samples obtained from patients with dry-eye disease who had rosacea-associated meibomian gland disease (MGD) or Sjögren’s syndrome (SS) aqueous tear deficiency (ATD) and normal asymptomatic subjects. The relative levels of expression of the IL-1 family of cytokines in the conjunctival epithelium of normal subjects and patients with SS ATD, the dry-eye condition that has been reported to involve the most severe KCS,³⁴ were compared using immunofluorescent staining. The activity of MMP-9, a protease that activates precursor IL-1ß in the extracellular environment was also evaluated. Finally, the tear fluid concentrations of lactoferrin, a protein secreted by the lacrimal glands into human tears that inhibits the formation of reactive oxygen species that can damage cells and promote production and release of IL-1 was measured.^{35 36}

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Materials
Rabbit anti-human polyclonal antibodies specific for IL-1, the precursor and mature forms of IL-1ß, and recombinant precursor and mature human IL-1ß and ELISA kits for the precursor and mature forms of IL-1ß were purchased from Cistron (Pine Brook, NJ); ELISA kits for IL-1 and IL-1Ra and recombinant human IL-1 and IL1-Ra and polyclonal antisera for IL-1Ra from R&D Systems (Minneapolis, MN); FITC-conjugated secondary antibodies from Caltag Laboratories (Burlingame, CA); and Texas red-conjugated secondary antibodies from Molecular Probes (Eugene, OR).

Patient Selection
This study was conducted according to a protocol approved by the University of Miami School of Medicine Institutional Review Board and in accordance with the tenets of the Declaration of Helsinki. Informed consent was obtained from participants after the nature and possible consequences of the study were explained.

Tear fluid samples were obtained from 9 patients with primary SS ATD, 1 patient with non-SS ATD, 13 patients with rosacea-associated MGD, and 17 normal subjects. The demographic characteristics of these patients are presented in Table 1 . One group of normal subjects consisted of six women and four men who had no history of eye disease or ocular surgery, did not use eye drops, and had no ocular irritation symptoms. All the subjects had a Schirmer 1 test score greater than 15 mm, normal meibomian glands, and no corneal fluorescein staining. This group was used for evaluating tear proteins in unstimulated tear fluid. A second group of asymptomatic normal subjects (four women and three men) who met the same criteria was used for evaluating the effects of reflex tearing on the concentration of the IL-1 family of cytokines in tear fluid. All normal subjects were recruited from the employees of the Bascom Palmer Eye Institute.

The MGD group consisted of seven women and six men with the chief symptoms of ocular irritation and/or redness that was diagnosed as ocular rosacea with MGD, according to previously reported criteria.³⁸ Corneal fluorescein staining was graded using a previously reported method.³⁹ The cornea was examined under blue-light illumination 2 minutes after instillation of 5 µl 2% fluorescein into the tear film. The intensity of the corneal fluorescein staining was graded in each of four quadrants on the cornea (temporal, nasal, superior, inferior) using a standardized four-point scale (0, no staining; 1, mild; 2, moderate; and 3, intense). The range of staining scores was 0 to 12. Patients with dry eye were excluded if they had any clinical signs of external ocular infection, including staphylococcal blepharitis or bacterial conjunctivitis.

Tear Fluid Collection and Sample Extraction
For experiments comparing the concentrations of proteins in unstimulated tear fluid, a tear fluid sample was collected from the inferior tear meniscus of both eyes, causing the least irritation possible, using a preweighed polyester wick (Transorb rods; American Filtrona, Richmond, VA) to obtain the sample, as previously described.^{11 40} The volume of collected tears was determined by reweighing the rods immediately after tear collection (model GA110 scale; Ohaus, Florham Park, NJ). Wicks were then placed into the end of a micropipette tip located within a 0.5-ml tube (Eppendorf, Fremont, CA) as described by Jones et al.⁴⁰ For experiments evaluating the concentrations of IL-1 cytokines in reflex tear fluid, an unstimulated tear fluid sample was collected, and reflex tearing was induced by placing a dry cotton-tipped applicator under the middle nasal turbinate, advancing it until the nasal membrane of the ethmoid sinus was reached, then rotating it for 1 minute as previously described.⁴¹ Tear fluid was then collected from the ipsilateral eye 1 and 5 minutes after stimulation.

Tears were extracted from the saturated wicks by centrifuging them at 12,000 rpm for 5 minutes within the pipette tip after adding a volume of buffer (50 mM Tris/HCl, 0.15 M NaCl, 10 mM CaCl₂, 0.005% Brij35, 0.02% sodium azide [pH 7.5]) 10 times greater than the original volume of the tear sample. The rods and pipette tips were carefully removed and the tear fluid aspirated. Tear fluid from both eyes was combined. This method resulted in a final tear dilution factor of 1:11 for the ELISA, gelatin zymography, and the MMP-9 activity assay. Tear samples were placed in numbered 500-µl tubes (Eppendorf) and stored at -80°C for 3 to 7 days until they were used.

Subjects with dry eye were not receiving any eye treatment other than nonpreserved artificial tears, and they were instructed not to instill any eye drops on the day the tear collection was performed. Tear collection was repeated on a separate day in all subjects, and both tear collections were performed in the morning. Tear fluid from one tear collection was used for cytokine ELISAs, and tear fluid from the second collection was used for the lactoferrin ELISA, gelatin zymography, and the MMP-9 activity assay.

IL-1, -1ß, and -1Ra and Lactoferrin ELISAs
The concentrations of IL-1 family cytokines were determined with commercial ELISA kits. For these assays, tear samples were diluted in ELISA buffer (supplied by the manufacturer) to a final volume of 100 to 200 µl. These assays were performed as recommended by the manufacturer. Tear lactoferrin concentration was measured with an immunoassay (Touch Tear MicroAssay System; Touch Scientific, Raleigh, NC).

Gelatin Zymography and MMP-9 Activity Assay
Gelatinase level in the tear fluid was measured by gelatin zymography, as previously described.¹¹ Diluted tear samples (all at a dilution of 1:11) were incubated with SDS-gel sample buffer for 30 minutes at room temperature and analyzed by electrophoresis on a 10% SDS-polyacrylamide gel containing 1 mg/ml gelatin. After electrophoresis, the proteins were renatured by removing SDS from the gel using two washes of 0.25% Triton X-100 (30 minutes per wash). This was followed by an 18-hour incubation at 37°C in the digestion buffer consisting of 50 mM Tris-HCl (pH 7.4) containing 0.15 M NaCl, 10 mM CaCl₂, 2 µM ZnSO_4, 1 mM phenylmethylsulfonyl fluoride (PMSF), 0.005% Brij35, and 0.02% sodium azide. After this incubation, the gel was briefly rinsed in distilled water and stained with 0.25% Coomassie brilliant blue R250 prepared in 40% isopropanol solution for 1 hour. The gel was destained with 7% acetic acid. Gelatinase activity in the gel was visible as a clear area in the blue background, indicating an area where the gelatin had been digested. The minimum sensitivity of this technique for detecting gelatinase B is 0.05 ng/lane. The molecular weight of gelatinases in the tear fluid was determined from molecular weight standards (prestained broad range standards; Bio-Rad, Hercules, CA) and 0.1 ng purified rabbit 92-kDa progelatinase B (Oncogene Research, Cambridge, MA) that were run in separate lanes on the gel. These gels were photographed with a camera (Polaroid, Cambridge, MA), and the photographs were scanned (Scan Jet 4C scanner; Hewlett-Packard, Palo Alto, CA) into a computer.

MMP-9 activity in tear fluid was measured with an MMP-9 activity assay system (Biotrak; Amersham Pharmacia Biotech, Piscataway, NJ), according to a previously published protocol.⁴² This colorimetric assay captures MMP-9 in the tear fluid and measures its activity in cleaving a modified prodetection enzyme and the subsequent cleavage of its chromogenic peptide substrate.⁴³

Immunofluorescent Staining of Conjunctival Impression Cytology and Conjunctival Biopsy Specimens
Impression Cytology.
The expression of four forms of IL-1 (IL-1, precursor and mature IL-1ß, and IL-1Ra) was evaluated in conjunctival impression cytology specimens obtained from 6 ideal normal subjects and 16 patients with SS ATD.

Impression cytology was performed by lightly pressing a membrane (Biopore; Millipore, Bedford, MA) against the nasal, inferior, and temporal bulbar conjunctiva, 1 mm behind the limbus after instillation of topical anesthesia (0.5% proparacaine hydrochloride). The membranes were placed in a container and stored at -80°C until they were processed. Before staining, these membranes were fixed with cold methanol for 10 minutes and were then blocked for 20 minutes with PBS containing 2% fetal bovine serum (FBS) to prevent nonspecific staining. The cytology specimens obtained from the nasal and temporal bulbar conjunctiva were bisected, and one of the four primary antibodies (IL-1, precursor and mature IL-1ß and -1Ra) was applied to each membrane for 1 hour at room temperature in a moist chamber. Membranes were rinsed three times with PBS and incubated for 1 hour with FITC-conjugated secondary antibody. The cytology specimens obtained from the inferior bulbar conjunctiva was treated only with secondary antibody and served as a negative control. Membranes were washed three times with PBS, placed on a glass microscope slide, and covered with nonfade mounting medium (Fluoromount-G; Southern Biotechnology Associates, Birmingham, AL) and a glass coverslip. Specimens were examined and photographed with a microscope (Axiophot II; Nikon, Tokyo, Japan) using TMAX 400 film (Eastman Kodak, Rochester, NY). The fluorescein staining was visually graded negative if the staining was less than or equal to the secondary antibody control and positive if it was greater than the secondary antibody control by two independent observers.

Conjunctival Biopsy.
Samples were taken from the superior or superotemporal bulbar conjunctiva of three normal subjects with Schirmer 1 test scores of 15 mm or more, no corneal fluorescein staining, and no lid or conjunctival inflammation, and three patients with SS KCS during cataract surgery. Tissue specimens were placed in DMEM (Life Technologies, Gaithersburg, MD) for transport and then were embedded in optimal cutting temperature (OCT) compound (Tissue Tek, Elkhart, IN), rapidly frozen in liquid nitrogen, and stored at -70°C. Within 72 hours, serial 4- to 5-µm-thick sections were cut. Indirect immunofluorescence staining on tissue sections was performed by a previously reported technique,⁴⁴ using polyclonal antibodies for IL-1, -1ß, and -1Ra at a concentration of 50 µg/ml and FITC-labeled secondary antibodies. The specificity of these antibodies was evaluated by neutralization with their corresponding recombinant human cytokine proteins according to the manufacturer’s instructions. Primary antibodies were incubated for 1 hour at 37°C (0.002 µg/ml anti-IL-1 or anti-IL-1ß antibodies with 50 pg/ml of their respective recombinant proteins and 1 µg/ml anti-IL-1Ra antibody with 50 ng/ml of its recombinant protein), before applying the mixture to tissue sections. Some sections were treated with the secondary antibody alone as a negative control. Slides were photographed as for the assays described earlier.

Statistics
Student’s t-test or Mann-Whitney test were used when appropriate for comparing the ELISA results between groups. One-way ANOVA and Wilcoxon paired tests were used to compare pre- and poststimulation tear cytokine concentrations. The ELISA data are expressed as means ± SD, and the differences were considered statistically significant at P < 0.05. The t-distribution was used to determine whether correlation coefficients were different from zero.⁴⁵

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Profile of IL-1 Cytokines in Tear Fluid
The concentrations of the IL-1 family of cytokines in basal tear fluid collected from normal subjects and patients with MGD and SS ATD are presented in Table 2 . The concentration of IL-1 was significantly higher in the tear fluid of both dry-eye groups than in the normal group. The precursor form of IL-1ß was the predominant form of this cytokine in normal tear fluid with a mean precursor-to-mature ratio of 19.1 ± 14.2. IL-1Ra was also detected in normal tear fluid with a ratio to IL-1 and precursor IL-1ß of more than 27,000 and more than 40,000, respectively. Compared with normal eyes, there was a statistically significant increase in the concentration of mature IL-1ß and a decrease in the concentration of precursor IL-1ß in the tear fluid of patients with MGD and SS ATD. These changes resulted in significantly lower ratios of the precursor-to-mature forms of IL-1ß in both dry-eye groups. There was no significant difference in the concentration of IL-1Ra among the three groups; however, the ratio of IL-1Ra to IL-1 was significantly lower in the two dry-eye groups and the IL-1Ra-to-IL-1ß ratio was significantly decreased in the MGD group compared with the control group. A strong correlation was observed between the clinical intensity of corneal fluorescein staining and the log of the tear IL-1 concentration (Fig. 1A) and between the corneal fluorescein staining score and the precursor-mature IL-1ß ratio (Fig. 1B) .

View larger version (15K): [in this window] [in a new window]   Figure 1. (A) Correlation between IL-1 concentration in tears and corneal fluorescein staining scores. (B) Correlation between mature-precursor IL-1ß ratio in tears and corneal fluorescein staining scores.

View this table: [in this window] [in a new window]   Table 3. Poststimulation Tear Fluid Concentrations of IL-1, Precursor IL-1ß, and IL-1Ra in Seven Normal Subjects

View larger version (14K): [in this window] [in a new window]   Figure 2. Lactoferrin concentration in tears from normal subjects, patients with MGD, and patients with SS ATD. *P < 0.01 compared with patients with SS.

View larger version (60K): [in this window] [in a new window]   Figure 3. Gelatin zymogram of tear samples from a normal subject, two patients with MGD, a patient with non-SS ATD, and two patients with SS ATD. The 92-kDa pro-MMP-9 and 72-kDa pro-MMP-2 bands are marked. Sample SS2 (right lane) was obtained from a 75-year-old patient with SS who had a 30-year history of bilateral recurrent sterile corneal ulceration with perforation.

View larger version (17K): [in this window] [in a new window]   Figure 4. MMP-9 activity in tear samples of normal subjects, patients with MGD, and patients with SS ATD, measured by an MMP-9 activity assay. *P < 0.001 compared with normal subjects.

View larger version (113K): [in this window] [in a new window]   Figure 5. Expression of the IL-1 family of cytokines in apical conjunctival epithelial impression cytology samples from normal subjects and patients with SS ATD. (A, B) Staining with IL-1–specific antibody in cytology membranes from normal (A) and SS ATD (B) eyes; (C, D) staining with precursor IL-1ß–specific antibody in cytology membranes from normal (C) and SS ATD (D) eyes; (E, F) staining with mature IL-1ß–specific antibody in cytology membranes from normal (E) and SS ATD (F) eyes; (G, H) staining with IL-1Ra–specific antibody in cytology membranes from normal (G) and SS ATD (H) eyes. Original magnification, x200.

View larger version (44K): [in this window] [in a new window]   Figure 6. Immunofluorescent staining of a conjunctival specimen from a patient with SS ATD. Top: sections stained with IL-1–specific antibody (A) without and (B) with preincubation of the antibody with recombinant IL-1 and (C) with the secondary antibody alone. Middle: sections stained with IL-1ß–specific antibody (D) without and (E) with preincubation of the antibody with recombinant IL-1ß and (F) with the secondary antibody alone. Bottom: sections stained with IL-1Ra–specific antibody (G) without and (H) with preincubation of the antibody with recombinant IL-1Ra and (I) with the secondary antibody alone. The epithelium in sections (C), (F), and (I) is outlined by dotted lines. Original magnification, x200.

View larger version (67K): [in this window] [in a new window]   Figure 7. Immunofluorescent staining of a conjunctival specimen taken from a normal subject. Top: sections stained with IL-1–specific antibody (A) and with secondary antibody alone (B). Middle: sections stained with IL-1ß–specific antibody (C) and with secondary antibody alone (D). Bottom: sections stained with IL-1Ra–specific antibody (E) and with secondary antibody alone (F). The epithelium is outlined by dotted lines. Original magnification, x200.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

Significant differences were observed in the level of the proinflammatory IL-1 cytokines in tear fluid obtained from both dry-eye groups compared with that from the normal groups. Specifically, the concentrations of IL-1 and mature IL-1ß were increased, and the concentration of precursor IL-1ß was decreased in tear fluid of the patients with dry eye compared with the mean concentrations of these cytokines in tear fluid obtained from both groups of normal subjects. One possible explanation for these differences is age. Tear fluid samples were obtained from two different groups of normal subjects in our study, one with a significantly lower age than the MGD and SS ATD groups and the other with an average age similar to that of the patients with MGD. Despite the similar age, the latter normal group had significantly different concentrations of IL-1 and precursor and mature IL-1ß than the patients with dry eye. In a previously reported study by our group, we observed that the IL-1 concentration in the tear fluid increases with age, yet the concentration of this cytokine is still significantly lower in age-matched control subjects than in patients with ocular rosacea.³⁸ Taken together, the findings from these two studies suggest that differences in the concentration of IL-1 cytokines observed between normal subjects and patients with dry eye are not due to age alone and may be related to changes in the ocular surface environment that accompany dry eye. Indeed, this hypothesis is supported by our finding that the tear fluid of IL-1ß increases within 4 days of experimentally inducing aqueous tear production in mice with the anticholinergic agent scopolamine.⁴⁷

The biologically inactive precursor IL-1ß was the predominant form of this cytokine in normal tear fluid, present at a concentration over 10 times greater than the mature, biologically active form. It is likely that precursor IL-1ß remains biologically inactive on the ocular surface until conditions, such as increased protease activity, signal its activation. Intracellular activation of precursor IL-1ß occurs primarily by the cysteine protease ICE.^{12 48} There is increasing recognition that precursor IL-1ß may be released into the extracellular environment where it can be activated by a number of extracellular proteases.²⁵ Studies have indicated that one of the most efficient proteases that activates precursor IL-1ß is MMP-9.²⁵ In our study MMP-9 activity was significantly higher in the tear fluid of patients with MGD and SS ATD than in normal subjects. We have recently reported that MMP-9 activates recombinant precursor IL-1ß, increasing its biological activity in stimulating MMP-1 (interstitial collagenase) and MMP-3 (stromelysin-1) by cultured human keratocytes.⁴⁹

Whether ICE, MMP-9, or other proteases mediate it, conditions on the ocular surface of patients with dry eye appear to promote the conversion of precursor IL-1ß to its mature form. We observed a significant decrease in the precursor-mature IL-1ß ratio from 19 in normal tear fluid to 1 and 0.4 in tear fluid obtained from patients with MGD and SS ATD, respectively. An increasing percentage of the mature form of IL-1ß in the tear fluid showed very strong correlation with the intensity of ocular surface dye staining, suggesting that IL-1ß itself, the conditions that favor this conversion, or factors that IL-1ß stimulates play an important role in the pathogenesis of KCS.

Normal tear fluid was found to contain high concentrations of the anti-inflammatory form of IL-1 (IL-1Ra) in concentrations 25,000 and 40,000 times greater than both proinflammatory forms. The high concentration of IL-1Ra in the tear fluid may be a natural homeostatic mechanism for preventing inappropriate activation of IL-1–mediated inflammatory events on the ocular surface.^{12 19} IL-1Ra functions by competitively inhibiting the binding of the proinflammatory forms of IL-1 to their type 1 signal-transducing receptor that is responsible for initiating the cascade of IL-1–mediated inflammatory events. IL-1Ra must be present in concentrations greatly in excess (15- to 102-fold) of the proinflammatory forms, to be biologically active.²⁶ The necessity of having such a large excess may be explained by the "spare receptor" effect. Target cells typically express thousands of type I IL-1 receptors, yet the expression of only a few receptors per cell is required to initiate a full biological response.^{19 26} Therefore, a large excess of IL-1Ra is required to flood the system to block the occupancy of even a few receptors by IL-1.

IL-1Ra is an inducible gene that is typically upregulated in inflammatory conditions, such as rheumatoid arthritis.²⁶ We have reported that IL-1Ra is upregulated in human corneal epithelial cultures that have been stimulated with lipopolysaccharide (LPS).⁴⁹ As might be expected, we detected an increased concentration of IL-1Ra in the tear fluid of patients with dry eye and in the conjunctival epithelium of patients with SS KCS. The immunofluorescent staining results in our study (Fig. 6) suggest that some of the IL-1Ra on the ocular surface of patients with SS KCS may be derived from inflammatory cells infiltrating the conjunctival epithelium. Despite the increased level of expression, the ratio of IL-1Ra to IL-1 in both dry-eye groups and the ratio of IL-1Ra to mature IL-1ß in patients with MGD was significantly lower than in normal subjects. Reports of placebo-controlled clinical trials in which IL-1Ra was administered to patients with rheumatoid arthritis have noted that increasing the ratio of IL-1Ra to the proinflammatory forms significantly improves clinical symptoms.⁵⁰ Additional studies are needed to determine the optimum balance between IL-1Ra and IL-1 and -1ß on the ocular surface to suppress IL-1–mediated bioactivity.

	Footnotes

 
Supported in part by Fight-for-Sight Postdoctoral Fellowship PD98025; Grant EY11915, National Eye Institute, Bethesda, Maryland; an unrestricted grant from Research to Prevent Blindness; and the Drs. David and Maureen Smith Ocular Surface and Tear Research Fund.

Submitted for publication February 2, 2001; revised April 20, 2001; accepted May 15, 2001.

Commercial relationships policy: N.

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. 1734 solely to indicate this fact.

Corresponding author: Stephen C. Pflugfelder, Cullen Eye Institute, 6565 Fannin, NC 205, Houston, TX 77030. stevenp{at}bcm.tmc.edu

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Jones, DT, Yen, M, Monroy, D, Ji, X, Atherton, SS, Pflugfelder, SC (1994) Evaluation of cytokine expression in the conjunctival epithelia of Sjögren’s syndrome patients Invest Ophthalmol Vis Sci 35,3493-3504[Abstract/Free Full Text]
2. Baudouin, C, Brignole, F, Becquet, F, Pisella, PJ, Goguel, A. (1997) Flow cytometry in impression cytology specimens: a new method for evaluation of conjunctival inflammation Invest Ophthalmol Vis Sci 38,1458-1464[Abstract/Free Full Text]
3. Brignole, F, Pisella, PJ, Goldschild, M, De Saint, Jean M, Goguel, A, Baudouin, C (2000) Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes Invest Ophthalmol Vis Sci 41,1356-1363[Abstract/Free Full Text]
4. Pflugfelder, SC, Huang, AJW, Schuclovski, PT, Pereira, IC, Tseng, SCG (1990) Conjunctival cytological features of primary Sjögren’s syndrome Ophthalmology 97,985-991[Medline][Order article via Infotrieve]
5. Kunert, KS, Tisdale, AS, Stern, ME, Smith, JA, Gipson, IK (2000) Analysis of topical cyclosporine treatment on patients with dry eye: effect on conjunctival lymphocytes Arch Ophthalmol 118,1489-1496[Abstract/Free Full Text]
6. Raphael, M, Bellefqih, S, Piette, JCH, Le Hoang, PH, Debre, P, Chomette, G. (1988) Conjunctival biopsy in Sjögren’s syndrome: correlations between histological and immunohistochemical features Histopathology 13,191-202[Medline][Order article via Infotrieve]
7. Power, WJ, Mullaney, P, Farrel, M, Collum, L. (1993) Effect of topical cyclosporin A on conjunctival T cells in patients with primary Sjögren’s syndrome Cornea 12,507-511[Medline][Order article via Infotrieve]
8. Marsh, P, Pflugfelder, SC (1999) Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren’s syndrome Ophthalmology 106,811-816[Medline][Order article via Infotrieve]
9. Sall, K, Stevenson, OD, Mundorf, TK, Reis, BL (2000) CSA phase 3 study group: two multicenter, randomized studies of the efficacy and safety of cyclosporin ophthalmic emulsion in moderate to severe dry eye disease Ophthalmology 107,631-639[Medline][Order article via Infotrieve]
10. Pflugfelder, SC, Jones, D, Ji, Z, Afonso, A, Monroy, D. (1999) Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren’s syndrome keratoconjunctivitis sicca Curr Eye Res 19,201-211[Medline][Order article via Infotrieve]
11. Afonso, A, Sobrin, L, Monroy, DC, Selzer, M, Lokeshwar, B, Pflugfelder, SC (1999) Tear fluid gelatinase B activity correlates with IL-1 concentration and fluorescein tear clearance Invest Ophthalmol Vis Sci 40,2506-2512[Abstract/Free Full Text]
12. Dinarello, CA (1996) Biologic basis for interleukin-1 in disease Blood 15,2095-2147
13. Okusawa, S, Gelfand, JA, Ikejima, T, Connolly, RJ, Dinarello, CA (1988) Interleukin 1 induces a shock-like state in rabbits, synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition J Clin Invest 81,1162-1172
14. Jiang, Y, Genant, HK, Watt, I, et al (2000) A multicenter double-blind, dose ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores Arthritis Rheum 43,1001-1009[Medline][Order article via Infotrieve]
15. McDevitt, MJ, Wang, HY, Konbelman, C, et al (2000) Interleukin-1 genetic association with periodontitis in clinical practice J Periodontol 71,156-163[Medline][Order article via Infotrieve]
16. Rosenbaum, JT, Plank, ST, Huang, XN, Rich, L, Ansel, JC (1995) Detection of mRNA for the cytokines, interleukin-1 and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy Invest Ophthalmol Vis Sci 36,2151-2155[Abstract/Free Full Text]
17. Fabre, EJ, Bureau, J, Pouliquen, Y, Lorans, G. (1991) Binding sites for human interleukin 1, gamma interferon and tumor necrosis factor on cultured fibroblasts of normal corneas and keratoconus Curr Eye Res 10,585-592[Medline][Order article via Infotrieve]
18. Shams, NB, Reddy, CV, Watanabe, K, Elgebaly, SA, Hanninen, LA, Kenyonk, R. (1994) Increased interleukin-1 activity in the injured vitamin A-deficient cornea Cornea 13,156-166[Medline][Order article via Infotrieve]
19. Dinarello, CA, Wolff, SM (1993) The role of interleukin-1 in disease N Engl J Med 328,106-113[Free Full Text]
20. Bankers-Fulbright, JL, Kalli, KR, McLean, DJ (1996) IL-1 signal transduction Life Sci 59,61-83[Medline][Order article via Infotrieve]
21. Chrousos, GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation N Engl J Med 332,1351-1362[Free Full Text]
22. Fibbe, WE, Daha, MR, Hiemstra, PS, et al (1989) Interleukin 1 and poly(rI) poly(rC) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells Exp Hematol 17,229-234[Medline][Order article via Infotrieve]
23. Woessner, JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling FASEB J 5,2145-2154[Abstract]
24. Black, RA, Kronheim, SR, Sleath, PR (1989) Activation of interleukin-1ß by a co-induced protease FEBS Lett 247,386-390[Medline][Order article via Infotrieve]
25. Schonbeck, V, Mach, F, Libby, P. (1998) Generation of biologically active IL-1ß by matrix metalloproteinase a novel caspase-1 independent pathway of IL-1ß processing J Immunol 161,3340-3346[Abstract/Free Full Text]
26. Arend, WP (1993) Interleukin-1 receptor antagonist Adv Immunol 54,167-223[Medline][Order article via Infotrieve]
27. Dekaris, I, Yamada, J, Streilein, JW, Dana, MR (1999) Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts Curr Eye Res 19,456-459[Medline][Order article via Infotrieve]
28. Wilson, SE, Schultz, GS, Chesini, N, Weng, J, Yu-Guang, HE (1994) Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor and interleukin-1 proteins in the cornea Exp Eye Res 59,63-72[Medline][Order article via Infotrieve]
29. Wilson, SE, He, YG, Lloyd, SA (1992) EGF, EGF receptor, basic FGF, TGF ß-1, and interleukin-1 mRNA in human corneal epithelial cells and stromal fibroblasts Invest Ophthalmol Vis Sci 33,1756-1765[Abstract/Free Full Text]
30. Weng, J, Mohan, RR, Li, Q, Wilson, SE (1997) IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1ß expression in the cornea Cornea 16,465-471[Medline][Order article via Infotrieve]
31. Kennedy, MC, Rosenbaum, JT, Brown, J, et al (1995) Novel production of interleukin-1 receptor antagonist peptides in normal human cornea J Clin Invest 95,82-88
32. Gamache, DA, Dimitrijevich, SD, Weimer, LK, Spellman, JM, Graff, G, Janni, JM (1997) Secretion of proinflammatory cytokines by human conjunctival epithelial cells Ocul Immunol Inflamm 5,117-128[Medline][Order article via Infotrieve]
33. Nakamura, Y, Sotozono, C, Kinoshita, S. (1998) Inflammatory cytokines in normal human tears Curr Eye Res 17,673-676[Medline][Order article via Infotrieve]
34. Murillo-Lopez, F, Pflugfelder, SC (1996) Dry eye Krachmer, J Mannis, M Holland, E eds. The Cornea ,663-686 Mosby St. Louis.
35. Kuizenga, A, van Haeringen, Kijlstra A (1987) Inhibition of hydroxyl radical formation by human tears Invest Ophthalmol Vis Sci 28,305-313[Abstract/Free Full Text]
36. Barnes, PJ, Karin, M. (1997) Nuclear factor-kB: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336,1066-1071[Free Full Text]
37. Fox, RI, Robinson, CA, Curd, JG, Kozir, F, Howell, FV (1986) Sjögren’s syndrome: proposed criteria for classification Arthritis Rheum 29,577-585[Medline][Order article via Infotrieve]
38. Barton, K, Monroy, D, Nava, A, Pflugfelder, SC (1997) Inflammatory cytokines in tears of patients with ocular rosacea Ophthalmology 104,1868-1874[Medline][Order article via Infotrieve]
39. Macri, A, Pflugfelder, S. (2000) Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease Arch Ophthalmol 118,1632-1638[Abstract/Free Full Text]
40. Jones, DT, Monroy, D, Pflugfelder, SC (1997) A novel method of tear collection: comparison of glass capillary micropipettes with porous polyester rods Cornea 16,450-458[Medline][Order article via Infotrieve]
41. Tsubota, K. (1991) The importance of the Schirmer test with nasal stimulation Am J Ophthalmol 111,106-108[Medline][Order article via Infotrieve]
42. Sobrin, L, Selzer, MG, Lokeshwar, BL, Pflugfelder, SC (2000) Stromelysin (MMP-3) activates pro-MMP-9 secreted by corneal epithelial cells Invest Ophthalmol Vis Sci 41,1703-1709[Abstract/Free Full Text]
43. Konttinen, YT, Halinen, S, Hanemaaijer, R, et al (1998) Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjogren’s syndrome Matrix Biol 17,335-347[Medline][Order article via Infotrieve]
44. Liu, Z, Pflugfelder, SC (2000) Increased expression of the type 1 growth factor receptor family in the conjunctival epithelium of patients with keratoconjunctivitis Am J. Ophthalmol. 129,472-480[Medline][Order article via Infotrieve]
45. Armitage, P. (1971) Statistical Methods in Medical Research ,160-162 Blackwell Scientific Oxford, UK.
46. Tanda, N, Ohyama, H, Yamakawa, M, et al (1998) IL-1 beta and IL-6 in mouse parotid acinar cells: characterization of synthesis, storage and release Am J Pathol 274,G147-G156
47. Pflugfelder SC, Solomon A, Dursun D, Li D-Q. Dry eye and delayed tear clearance: a call to arms. Adv Exp Med Biol. In press.
48. Thornberry, NA, Bull, HG, Calaycay, JR, Chapman, K, Howard, A, Kostura, M. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes Nature 356,768-774[Medline][Order article via Infotrieve]
49. Solomon, A, Monroy, D, Rosenblatt, M, Ji, Z, Lokeshwar, BL, Pflugfelder, SC (2000) Doxycycline inhibition of interleukin-1 in the corneal epithelium Invest Ophthalmol Vis Sci 41,2544-2557[Abstract/Free Full Text]
50. Dinarello, CA (2000) The role of interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1 N Engl J Med 343,732-734[Free Full Text]

This article has been cited by other articles:

				A. P. Simopoulos The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases Experimental Biology and Medicine, June 1, 2008; 233(6): 674 - 688. [Abstract] [Full Text] [PDF]

				V A Smith, D Khan-Lim, L Anderson, S D Cook, and A D Dick Does orally administered doxycycline reach the tear film? Br. J. Ophthalmol., June 1, 2008; 92(6): 856 - 859. [Abstract] [Full Text] [PDF]

				T. D. Blalock, S. J. Spurr-Michaud, A. S. Tisdale, and I. K. Gipson Release of Membrane-Associated Mucins from Ocular Surface Epithelia Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1864 - 1871. [Abstract] [Full Text] [PDF]

				S. Rashid, Y. Jin, T. Ecoiffier, S. Barabino, D. A. Schaumberg, and M. R. Dana Topical Omega-3 and Omega-6 Fatty Acids for Treatment of Dry Eye Arch Ophthalmol, February 1, 2008; 126(2): 219 - 225. [Abstract] [Full Text] [PDF]

				S. Li, K. Nikulina, J. DeVoss, A. J. Wu, E. C. Strauss, M. S. Anderson, and N. A. McNamara Small Proline-Rich Protein 1B (SPRR1B) Is a Biomarker for Squamous Metaplasia in Dry Eye Disease Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 34 - 41. [Abstract] [Full Text] [PDF]

				T. Said, M. Dutot, R. Christon, J.-L. Beaudeux, C. Martin, J.-M. Warnet, and P. Rat Benefits and Side Effects of Different Vegetable Oil Vectors on Apoptosis, Oxidative Stress, and P2X7 Cell Death Receptor Activation Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5000 - 5006. [Abstract] [Full Text] [PDF]

				S. Selvam, P. B. Thomas, H. J. Gukasyan, A. S. Yu, D. Stevenson, M. D. Trousdale, A. K. Mircheff, J. E. Schechter, R. E. Smith, and S. C. Yiu Transepithelial bioelectrical properties of rabbit acinar cell monolayers on polyester membrane scaffolds Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1412 - C1419. [Abstract] [Full Text] [PDF]

				G P Williams, H S Mudhar, and M Leyland Early pathological features of the cornea in toxic epidermal necrolysis Br. J. Ophthalmol., September 1, 2007; 91(9): 1129 - 1132. [Abstract] [Full Text] [PDF]

				C. S. De Paiva, A. L. Villarreal, R. M. Corrales, H. T. Rahman, V. Y. Chang, W. J. Farley, M. E. Stern, J. Y. Niederkorn, D.-Q. Li, and S. C. Pflugfelder Dry Eye-Induced Conjunctival Epithelial Squamous Metaplasia Is Modulated by Interferon-{gamma} Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2553 - 2560. [Abstract] [Full Text] [PDF]

				K.-C. Yoon, C. S. De Paiva, H. Qi, Z. Chen, W. J. Farley, D.-Q. Li, and S. C. Pflugfelder Expression of Th-1 Chemokines and Chemokine Receptors on the Ocular Surface of C57BL/6 Mice: Effects of Desiccating Stress Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2561 - 2569. [Abstract] [Full Text] [PDF]